Clinical Trial Update: Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus

View source ↗

Summary

A completed clinical trial comparing oral semaglutide with subcutaneous semaglutide in type 2 diabetes mellitus, reporting the study results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• OZEMPIC (semaglutide)
• Rybelsus (semaglutide)

Snippet

Sponsor: University of Palermo | Conditions: Diabetes Mellitus Type 2 | Status: COMPLETED